Wilson Sonsini Goodrich & Rosati has advised 4E Therapeutics. 4E Therapeutics, an Austin-based neuroscience company, has announced its acquisition by Eli Lilly and Company (NYSE: LLY)....
Eli Lilly Acquires 4E Therapeutics to Expand Chronic Pain Treatment Portfolio
Distalmotion Secures $150 Million Series G Financing Led by Revival Healthcare Capital
Wilson Sonsini Goodrich & Rosati and Bär & Karrer have advised Revival Healthcare Capital on the deal. Walder Wyss has advised Distalmotion. Distalmotion SA, a global...
Revival and Olympus Launch Swan EndoSurgical with Up to $458 Million Joint Investment
Wilson Sonsini Goodrich & Rosati has advised Revival Healthcare Capital on the deal. Revival Healthcare Capital has entered into a strategic partnership with Olympus Corporation to...
QbDVision’s $13 Million Investment Round
Wilson Sonsini Goodrich & Rosati advised QbDVision on the transaction. QbDVision, an Austin, Texas-based digital chemistry, manufacturing, and controls (CMC) platform purpose-built for biopharma organizations, announced...
Bakkt’s Common Stock Offerings
Wilson Sonsini Goodrich & Rosati advised Bakkt Holdings, Inc. on the transaction, and Goodwin Procter advised the placement agent. Bakkt Holdings, Inc. (Bakkt) (NYSE: BKKT), a...
Bakkt’s Acquisition of Apex Crypto
Wilson Sonsini Goodrich & Rosati advised Bakkt on the deal. Digital asset platform Bakkt Holdings Inc. announced the acquisition of Apex Crypto LLC from Apex Fintech...
Distalmotion SA’s $90 Million Series E Financing Round
Walder Wyss advised Distalmotion in connection with the transaction. Bär & Karrer advised Revival Healthcare Capital alongside Wilson Sonsini in this transaction. Distalmotion SA, a young,...